e-therapeutics plc ETX.L Stock
e-therapeutics plc Price Chart
e-therapeutics plc ETX.L Financial and Trading Overview
| e-therapeutics plc stock price | 11.25 GBP |
| Previous Close | 22 GBP |
| Open | 22.24 GBP |
| Bid | 21 GBP x 0 |
| Ask | 22.4 GBP x 0 |
| Day's Range | 22.24 - 22.24 GBP |
| 52 Week Range | 10.05 - 24 GBP |
| Volume | 337 GBP |
| Avg. Volume | 279.33K GBP |
| Market Cap | 129.61M GBP |
| Beta (5Y Monthly) | 0.32567 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ETX.L Valuation Measures
| Enterprise Value | 103.2M GBP |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 272.86105 |
| Price/Book (mrq) | 390.25262 |
| Enterprise Value/Revenue | 217.264 |
| Enterprise Value/EBITDA | -10.146 |
Trading Information
e-therapeutics plc Stock Price History
| Beta (5Y Monthly) | 0.32567 |
| 52-Week Change | 38.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24 GBP |
| 52 Week Low | 10.05 GBP |
| 50-Day Moving Average | 14.51 GBP |
| 200-Day Moving Average | 16.89 GBP |
ETX.L Share Statistics
| Avg. Volume (3 month) | 279.33K GBP |
| Avg. Daily Volume (10-Days) | 552.22K GBP |
| Shares Outstanding | 582.66M |
| Float | 156.69M |
| Short Ratio | N/A |
| % Held by Insiders | 59.47% |
| % Held by Institutions | 28.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2023 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | January 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2155.57% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.95% |
| Return on Equity (ttm) | -27.22% |
Income Statement
| Revenue (ttm) | 475K GBP |
| Revenue Per Share (ttm) | 0.001 GBP |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -10172000 GBP |
| Net Income Avi to Common (ttm) | -8274000 GBP |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 31.69M GBP |
| Total Cash Per Share (mrq) | 0.05 GBP |
| Total Debt (mrq) | 295K GBP |
| Total Debt/Equity (mrq) | 0.89 GBP |
| Current Ratio (mrq) | 21.304 |
| Book Value Per Share (mrq) | 0.057 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8011000 GBP |
| Levered Free Cash Flow (ttm) | -5903750 GBP |
Profile of e-therapeutics plc
| Country | United Kingdom |
| State | N/A |
| City | London |
| Address | 4 Kingdom Street |
| ZIP | W2 6BD |
| Phone | 44 20 4551 8888 |
| Website | https://www.etherapeutics.co.uk |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 38 |
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.
Q&A For e-therapeutics plc Stock
What is a current ETX.L stock price?
e-therapeutics plc ETX.L stock price today per share is 11.25 GBP.
How to purchase e-therapeutics plc stock?
You can buy ETX.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for e-therapeutics plc?
The stock symbol or ticker of e-therapeutics plc is ETX.L.
Which industry does the e-therapeutics plc company belong to?
The e-therapeutics plc industry is Biotechnology.
How many shares does e-therapeutics plc have in circulation?
The max supply of e-therapeutics plc shares is 5.84M.
What is e-therapeutics plc Price to Earnings Ratio (PE Ratio)?
e-therapeutics plc PE Ratio is now.
What was e-therapeutics plc earnings per share over the trailing 12 months (TTM)?
e-therapeutics plc EPS is -0.02 GBP over the trailing 12 months.
Which sector does the e-therapeutics plc company belong to?
The e-therapeutics plc sector is Healthcare.
e-therapeutics plc ETX.L included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| FTSE AIM All-Share Index FTAI | 755.91 GBP 966.76 USD |
-0.38
|
— — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | — — |
- {{ link.label }} {{link}}